Top Healthcare Innovations Reshaping Oral Solid Dosage Contract Manufacturing

According to a newly published market research report by 24LifeSciences, global oral solid dosage contract manufacturing market is valued at USD 75.5 billion in 2026 and is projected to reach USD 117.2 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period.

Oral solid dosage (OSD) contract manufacturing involves outsourcing the production of solid-form pharmaceuticals, such as tablets, capsules, powders, and granules, to specialized third-party organizations.

Next Generation Cancer Diagnostics Market: Innovation-Driven Growth and Future Opportunities

According to a newly published market research report by 24LifeSciences, global next generation cancer diagnostics market was valued at USD 8,060 million in 2026 and is projected to reach USD 28,120 million by 2034, growing at a compound annual growth rate (CAGR) of 20.0% during the forecast period.

Next generation cancer diagnostics represent a paradigm shift from traditional histopathology. These advanced technologies enable highly sensitive and specific analysis of cancer biomarkers from various biological samples.

What Is the Future of the Surgical Scalpel Market? Growth Forecasts & Insights

According to a newly published market research report by 24LifeSciences, global surgical scalpel market was valued at USD 289 million in 2026 and is projected to reach USD 392 million by 2034, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period.

The surgical scalpel represents one of the most fundamental and essential instruments in modern medicine, serving as the primary cutting tool across countless surgical procedures.

Leading Players Driving Growth in the Global Cell Detachment and Dissociation Solution Market

According to a newly published market research report by 24LifeSciences, global cell detachment and dissociation solution market is valued at USD 547.8 million in 2026 and is projected to reach USD 882.4 million by 2034, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period.

Cell detachment and dissociation solutions are essential reagents in cell culture workflows, designed to effectively separate adherent cells from culture surfaces and dissociate them into viable single-cell suspensions.

Surface Plasmon Resonance Systems: Advancing Label-Free Detection

According to a newly published market research report by 24LifeSciences, global Surface Plasmon Resonance (SPR) System market was valued at USD 820 million in 2026 and is projected to reach USD 1.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period.

Surface Plasmon Resonance (SPR) is a label-free, real-time optical biosensing technology that enables detailed analysis of biomolecular interactions by detecting changes in refractive index on a sensor surface.